Summary
This curated, high-level summit will host up to 200 key participants, including prominent CNS investing VC funds, industry leaders, and CEOs of some of the most promising private companies in CNS neuroscience drug development.
Speaker
About this event
At Warman O’Brien, we are excited to share a unique opportunity for you to be part of Bio-Neuroscience, a groundbreaking initiative gathering leaders in CNS Neuroscience drug development. As a strategic partner of Bio-Neuroscience, we take pride in endorsing an initiative that brings together CEOs of leading and innovative companies, industry executives, and top investors.
When: 25-27 Feb 2025 | Where: Amsterdam
What to expect: This curated, high-level summit will host up to 200 key participants, including prominent CNS investing VC funds, industry leaders, and CEOs of some of the most promising private companies in CNS neuroscience drug development.
Renowned VC firms such as EQT Partners, F-Prime (Fidelity), Dolby Family Ventures, SR One, AbbVie Ventures, M-Ventures, Angelini Ventures, UCB Ventures, Ysios Capital, Asabys Partners, Lumira Capital, Neurvati (Blackstone), and many more will be actively participating, providing a unique opportunity to bridge leading entrepreneurs and CEOs with seasoned investors.
To learn more about the event and secure your spot, please click here to register.
Date and time
Tue
25
Feb, 2025
09:00 am
90 mins duration
Location
Ansterdam, the Netherdands
